Top highlights this week include: iPads and rashes, Alzheimer’s detection, Mayo Clinic named top spot on U.S. News and World Report’s Best Hospitals List, Mayo Clinic Hilton Building evacuation drill and protein for Alzheimer’s.
In Genetic Engineering & Biotechnology, David Smith, Ph.D., professor of laboratory medicine and pathology at the Mayo Clinic, discusses integrating and interpreting clinical genomics data.
Chronic hepatitis C virus (HCV) is the primary cause of cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver disease requiring liver transplantation. Mayo Medical Laboratories offers an assay for use to confirm the presence of chronic HCV infection, to determine pretreatment (baseline) HCV RNA levels in serum, and to monitor a patient’s response to antiviral therapy.
The FDA recently approved the first gene-based molecular assay, Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test, to be used in transfusion medicine for determining blood compatibility.
Top highlights this week include: Shortage of physician-scientists, Minnesota health insurance, bug spray application, Mayo Clinic discovers new type of cancer and changes in genetic testing recommendations.
Top highlights this week include: Scribes accompanying physicians, prostate cancer, non-small cell lung cancer, Apple iOS Health Monitor dashboard and ovarian cancer treatment.